Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population (ESMAA)

November 7, 2016 updated by: AstraZeneca

Evaluation of aSthma Management in Middle EAst Adult Population

Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE

Study Overview

Status

Completed

Conditions

Detailed Description

Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.

Study Type

Observational

Enrollment (Actual)

7294

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Algeria
    • Nis-rme-xxx-2014/1
      • Ain Beida, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Ain Naadja, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Alger, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Annaba, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Azzaba, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bab Ezzouar, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bab el Oued, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Babez, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Batna, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bejaia, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Beni Messous, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Birkhadem, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Blida, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bordj Bou Arreridj, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bordj Menail, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bouira, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Bouzareah, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Constantine, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • El Eulma, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Essania, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Gouraya, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Lakhdaria, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Larbaa, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Mascara, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Meftah, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Mila, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Misserghine, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Mostaghanem, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Msila, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Oran, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Rouiba, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Setif, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Sidi Bel Abbes, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Tiaret, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Tipaza, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Tizi Ouzou, Nis-rme-xxx-2014/1, Algeria
        • Research Site
      • Zeralda, Nis-rme-xxx-2014/1, Algeria
        • Research Site
  • Egypt
    • Nis-rme-xxx-2014/1
      • Alexandria, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Cairo, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Domyat - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Giza - Cairo, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Ismalia - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Mansoura - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Menofia - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Menoufia - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Portsaid - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Tanta - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
      • Zagazig - Delta, Nis-rme-xxx-2014/1, Egypt
        • Research Site
  • Iran, Islamic Republic of
    • Nis-rme-xxx-2014/1
      • Ahwaz, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Isfahan, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Karaj, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Kerman, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Mashhad, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Rasht, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Sari, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Shiraz, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Tabriz, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Tehran, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
      • Yazd, Nis-rme-xxx-2014/1, Iran, Islamic Republic of
        • Research Site
  • Iraq
    • Nis-rme-xxx-2014/1
      • Baghdad, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Basra, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Erbil, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Hilla, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Najaf, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Nasria, Nis-rme-xxx-2014/1, Iraq
        • Research Site
      • Sulaimania, Nis-rme-xxx-2014/1, Iraq
        • Research Site
  • Jordan
    • Nis-rme-xxx-2014/1
      • Al Salt, Nis-rme-xxx-2014/1, Jordan
        • Research Site
      • Amman, Nis-rme-xxx-2014/1, Jordan
        • Research Site
      • Irbid, Nis-rme-xxx-2014/1, Jordan
        • Research Site
      • Madaba, Nis-rme-xxx-2014/1, Jordan
        • Research Site
      • Rusaifa, Nis-rme-xxx-2014/1, Jordan
        • Research Site
      • Zarqa, Nis-rme-xxx-2014/1, Jordan
        • Research Site
  • Kuwait
    • Nis-rme-xxx-2014/1
      • Kuwait, Nis-rme-xxx-2014/1, Kuwait
        • Research Site
    • Nis-rme-xxx-2014/2
      • Kuwait, Nis-rme-xxx-2014/2, Kuwait
        • Research Site
    • Nis-rme-xxx-2014/5
      • Kuwait, Nis-rme-xxx-2014/5, Kuwait
        • Research Site
  • Lebanon
    • Nis-rme-xxx-2014/1
      • Bkaa, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • Chweifat, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • Dahieh, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • East Beirut, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • Keserwen, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • Maten, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • North Beirut, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • South Beirut, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • South Metn, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
      • West Beirut, Nis-rme-xxx-2014/1, Lebanon
        • Research Site
  • Qatar
    • Nis-rme-xxx-2014/1
      • Doha, Nis-rme-xxx-2014/1, Qatar
        • Research Site
  • Saudi Arabia
    • Nis-rme-xxx-2014/1
      • Al Hada, Nis-rme-xxx-2014/1, Saudi Arabia
        • Research Site
      • Al Khobar, Nis-rme-xxx-2014/1, Saudi Arabia
        • Research Site
      • Dammam, Nis-rme-xxx-2014/1, Saudi Arabia
        • Research Site
      • Jeddah, Nis-rme-xxx-2014/1, Saudi Arabia
        • Research Site
      • Riyadh, Nis-rme-xxx-2014/1, Saudi Arabia
        • Research Site
  • Tunisia
    • Nis-rme-xxx-2014/1
      • Sfax, Nis-rme-xxx-2014/1, Tunisia
        • Research Site
      • Sousse, Nis-rme-xxx-2014/1, Tunisia
        • Research Site
      • Tunis, Nis-rme-xxx-2014/1, Tunisia
        • Research Site
  • United Arab Emirates
    • Nis-rme-xxx-2014/1
      • Abu Dhabi, Nis-rme-xxx-2014/1, United Arab Emirates
        • Research Site
      • Al Ain, Nis-rme-xxx-2014/1, United Arab Emirates
        • Research Site
      • Dubai, Nis-rme-xxx-2014/1, United Arab Emirates
        • Research Site
      • Sharjah, Nis-rme-xxx-2014/1, United Arab Emirates
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 130 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

Description

Inclusion Criteria:

Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

Exclusion Criteria:

  • Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
8645 asthmatic patients
Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asthma control
Time Frame: Up to 1 year
Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)
Up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
general and sociodemographic patient's characteristics
Time Frame: up to 1 year
sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage.
up to 1 year
Identify predictive factors of asthma control,
Time Frame: UP to 1 year
such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity.
UP to 1 year
asthma control level
Time Frame: Up to 4 weeks
Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment
Up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 30, 2014

First Submitted That Met QC Criteria

May 30, 2014

First Posted (Estimate)

June 3, 2014

Study Record Updates

Last Update Posted (Estimate)

November 8, 2016

Last Update Submitted That Met QC Criteria

November 7, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-RME-XXX-2014/1 (Registry Identifier: NIS Registry)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe